• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞 gp96 通过阻断 NR5A2 的 SUMO 化和泛素化来上调肝癌中 AFP 的表达。

Cellular gp96 upregulates AFP expression by blocking NR5A2 SUMOylation and ubiquitination in hepatocellular carcinoma.

机构信息

Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.

University of Chinese Academy of Science, Beijing 100049, China.

出版信息

J Mol Cell Biol. 2023 Nov 27;15(5). doi: 10.1093/jmcb/mjad027.

DOI:10.1093/jmcb/mjad027
PMID:37204028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10748477/
Abstract

Alpha-fetoprotein (AFP) is the most widely used biomarker for the diagnosis of hepatocellular carcinoma (HCC). However, a substantial proportion of HCC patients have either normal or marginally increased AFP levels in serum, and the underlying mechanisms are not fully understood. In the present study, we provided in vitro and in vivo evidence that heat shock protein gp96 promoted AFP expression at the transcriptional level in HCC. NR5A2 was identified as a key transcription factor for the AFP gene, and its stability was enhanced by gp96. A further mechanistic study by co-immunoprecipitation, GST pull-down, and molecular docking showed gp96 and the SUMO E3 ligase RanBP2 competitively binding to NR5A2 at the sites spanning from aa 507 to aa 539. The binding of gp96 inhibited SUMOylation, ubiquitination, and subsequent degradation of NR5A2. In addition, clinical analysis of HCC patients indicated that gp96 expression in tumors was positively correlated with serum AFP levels. Therefore, our study uncovered a novel mechanism that gp96 regulates the stability of its client proteins by directly affecting their SUMOylation and ubiquitination. These findings will help in designing more accurate AFP-based HCC diagnosis and progression monitoring approaches.

摘要

甲胎蛋白(AFP)是诊断肝细胞癌(HCC)最常用的生物标志物。然而,相当一部分 HCC 患者的血清 AFP 水平正常或略有升高,其潜在机制尚不完全清楚。在本研究中,我们提供了体外和体内证据,表明热休克蛋白 gp96 在 HCC 中以转录水平促进 AFP 的表达。NR5A2 被鉴定为 AFP 基因的关键转录因子,其稳定性被 gp96 增强。通过免疫共沉淀、GST 下拉和分子对接的进一步机制研究表明,gp96 和 SUMO E3 连接酶 RanBP2 在跨越 aa507 至 aa539 的位点上竞争结合 NR5A2。gp96 的结合抑制了 NR5A2 的 SUMO 化、泛素化和随后的降解。此外,对 HCC 患者的临床分析表明,肿瘤中 gp96 的表达与血清 AFP 水平呈正相关。因此,我们的研究揭示了一种新的机制,即 gp96 通过直接影响其客户蛋白的 SUMO 化和泛素化来调节其稳定性。这些发现将有助于设计更准确的基于 AFP 的 HCC 诊断和进展监测方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/d94970079793/mjad027fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/395ee163b95c/mjad027fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/5bc4b0b891fc/mjad027fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/b13537603c2e/mjad027fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/38c277c818fe/mjad027fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/e227b45e8dc6/mjad027fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/4089979fba2f/mjad027fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/e152aa1cb60d/mjad027fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/d94970079793/mjad027fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/395ee163b95c/mjad027fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/5bc4b0b891fc/mjad027fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/b13537603c2e/mjad027fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/38c277c818fe/mjad027fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/e227b45e8dc6/mjad027fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/4089979fba2f/mjad027fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/e152aa1cb60d/mjad027fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/465d/10748477/d94970079793/mjad027fig8.jpg

相似文献

1
Cellular gp96 upregulates AFP expression by blocking NR5A2 SUMOylation and ubiquitination in hepatocellular carcinoma.细胞 gp96 通过阻断 NR5A2 的 SUMO 化和泛素化来上调肝癌中 AFP 的表达。
J Mol Cell Biol. 2023 Nov 27;15(5). doi: 10.1093/jmcb/mjad027.
2
Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.茵陈色原酮通过下调肝癌中 AFP 基因的表达促进肝癌细胞凋亡并抑制其增殖。
BMC Cancer. 2021 Mar 25;21(1):318. doi: 10.1186/s12885-021-08043-9.
3
FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.FBXO22 通过调控 p21 的泛素化降解促进肝细胞癌的发展。
J Exp Clin Cancer Res. 2019 Feb 26;38(1):101. doi: 10.1186/s13046-019-1058-6.
4
Low levels of glycoprotein 96 indicate a worse prognosis in early-stage hepatocellular carcinoma patients after hepatectomy.糖蛋白 96 水平低表明肝癌患者肝切除术后早期预后较差。
Hum Pathol. 2019 Apr;86:193-202. doi: 10.1016/j.humpath.2018.11.025. Epub 2018 Dec 8.
5
Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma.甲胎蛋白对肝细胞癌发生发展的影响。
J Cancer Res Clin Oncol. 2020 Oct;146(10):2439-2446. doi: 10.1007/s00432-020-03331-6. Epub 2020 Jul 28.
6
Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.乙型肝炎病毒 X 蛋白通过靶向 miR-1236 和 miR-329 上调甲胎蛋白促进肝细胞癌。
J Cell Biochem. 2020 Mar;121(3):2489-2499. doi: 10.1002/jcb.29471. Epub 2019 Nov 3.
7
Heat shock protein gp96 decreases p53 stability by regulating Mdm2 E3 ligase activity in liver cancer.热休克蛋白gp96通过调节肝癌中Mdm2 E3连接酶活性降低p53稳定性。
Cancer Lett. 2015 Apr 10;359(2):325-34. doi: 10.1016/j.canlet.2015.01.034. Epub 2015 Jan 28.
8
Interaction between heat shock protein 72 and alpha-fetoprotein in human hepatocellular carcinomas.人肝细胞癌中热休克蛋白72与甲胎蛋白之间的相互作用
Clin Chim Acta. 2007 Apr;379(1-2):158-62. doi: 10.1016/j.cca.2006.12.015. Epub 2006 Dec 29.
9
Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progression.乙酰化甲胎蛋白促进肝细胞癌进展。
Cancer Lett. 2020 Feb 28;471:12-26. doi: 10.1016/j.canlet.2019.11.043. Epub 2019 Dec 5.
10
Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation.α-甲胎蛋白(AFP)作为肝移植后肝细胞癌复发生物标志物的诊断价值。
Clin Biochem. 2018 Feb;52:20-25. doi: 10.1016/j.clinbiochem.2017.10.011. Epub 2017 Oct 17.

引用本文的文献

1
Nuclear pore complex protein RANBP2 and related SUMOylation in solid malignancies.核孔复合体蛋白RANBP2及相关的SUMO化修饰在实体恶性肿瘤中的作用
Genes Dis. 2024 Sep 4;12(4):101407. doi: 10.1016/j.gendis.2024.101407. eCollection 2025 Jul.
2
MRI Radiomics Combined with Clinicopathological Factors for Predicting 3-Year Overall Survival of Hepatocellular Carcinoma After Hepatectomy.MRI影像组学联合临床病理因素预测肝癌肝切除术后3年总生存率
J Hepatocell Carcinoma. 2024 Jul 18;11:1445-1457. doi: 10.2147/JHC.S464916. eCollection 2024.
3
NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by OCLR algorithm and immune score.

本文引用的文献

1
The biology and inhibition of glucose-regulated protein 94/gp96.葡萄糖调节蛋白 94/gp96 的生物学特性及其抑制作用。
Med Res Rev. 2022 Nov;42(6):2007-2024. doi: 10.1002/med.21915. Epub 2022 Jul 21.
2
An internalizing antibody targeting of cell surface GRP94 effectively suppresses tumor angiogenesis of colorectal cancer.针对细胞表面 GRP94 的内化抗体可有效抑制结直肠癌的肿瘤血管生成。
Biomed Pharmacother. 2022 Jun;150:113051. doi: 10.1016/j.biopha.2022.113051. Epub 2022 May 10.
3
FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth.
NR5A2基因通过OCLR算法和免疫评分,经由SNP途径调节癌症干细胞活性,从而影响肺腺癌患者的总生存期。
Heliyon. 2024 Mar 28;10(7):e28282. doi: 10.1016/j.heliyon.2024.e28282. eCollection 2024 Apr 15.
4
Abnormal protein SUMOylation in liver disease: novel target for therapy.肝脏疾病中异常的蛋白质 SUMOylation:治疗的新靶点。
J Mol Med (Berl). 2024 Jun;102(6):719-731. doi: 10.1007/s00109-024-02440-w. Epub 2024 Apr 3.
5
NR5A2 promotes malignancy progression and mediates the effect of cisplatin in cutaneous squamous cell carcinoma.NR5A2 促进皮肤鳞状细胞癌的恶性进展并介导顺铂的作用。
Immun Inflamm Dis. 2024 Feb;12(2):e1172. doi: 10.1002/iid3.1172.
FBXL2 通过拮抗 Grp94 来使 EGFR 不稳定,从而抑制 EGFR 驱动的 NSCLC 生长。
Nat Commun. 2021 Oct 11;12(1):5919. doi: 10.1038/s41467-021-26222-x.
4
RANBP2 Activates -GlcNAcylation through Inducing CEBPα-Dependent OGA Downregulation to Promote Hepatocellular Carcinoma Malignant Phenotypes.RANBP2通过诱导CEBPα依赖的OGA下调激活O-连接N-乙酰葡糖胺化,以促进肝癌恶性表型。
Cancers (Basel). 2021 Jul 12;13(14):3475. doi: 10.3390/cancers13143475.
5
Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target.癌症中的分子伴侣GRP94/GP96:肿瘤发生与治疗靶点
Front Oncol. 2021 Apr 9;11:629846. doi: 10.3389/fonc.2021.629846. eCollection 2021.
6
Emerging functions of the nuclear receptor LRH-1 in liver physiology and pathology.核受体 LRH-1 在肝脏生理和病理中的新兴功能。
Biochim Biophys Acta Mol Basis Dis. 2021 Aug 1;1867(8):166145. doi: 10.1016/j.bbadis.2021.166145. Epub 2021 Apr 20.
7
Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy.细胞表面 GRP94 作为单克隆抗体癌症治疗的新型新兴治疗靶点。
Cells. 2021 Mar 17;10(3):670. doi: 10.3390/cells10030670.
8
The RanBP2/RanGAP1-SUMO complex gates β-arrestin2 nuclear entry to regulate the Mdm2-p53 signaling axis.RanBP2/RanGAP1-SUMO 复合物控制β-arrestin2 的核输入,从而调节 Mdm2-p53 信号通路。
Oncogene. 2021 Mar;40(12):2243-2257. doi: 10.1038/s41388-021-01704-w. Epub 2021 Mar 1.
9
Functions of nuclear receptors SUMOylation.核受体SUMO化修饰的功能。
Clin Chim Acta. 2021 May;516:27-33. doi: 10.1016/j.cca.2021.01.007. Epub 2021 Jan 18.
10
Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma.甲胎蛋白对肝细胞癌发生发展的影响。
J Cancer Res Clin Oncol. 2020 Oct;146(10):2439-2446. doi: 10.1007/s00432-020-03331-6. Epub 2020 Jul 28.